Drugs approved for diabetes and obesity might be useful for the treatment of cognitive and mental health disorders, according ...
On February 18, 2025, the United States Court of Appeals for the First Circuit issued its opinion in United States v. Regeneron Pharmaceuticals Inc., finding that, in Anti-Kickback Statute (AKS) cases ...